Cargando…
Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report
BACKGROUND: Anticoagulation treatment after lower limb surgery is one of the key methods to avoid thrombosis, and low-molecular-weight heparin is the treatment that is most frequently used in clinical practice. But one uncommon side effect of low-molecular-weight heparin is heparin-induced thrombocy...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507566/ https://www.ncbi.nlm.nih.gov/pubmed/37731576 http://dx.doi.org/10.12998/wjcc.v11.i26.6147 |
_version_ | 1785107345821401088 |
---|---|
author | Lv, Fang-Fang Li, Mei-Ye Qu, Wei Jiang, Zhao-Shun |
author_facet | Lv, Fang-Fang Li, Mei-Ye Qu, Wei Jiang, Zhao-Shun |
author_sort | Lv, Fang-Fang |
collection | PubMed |
description | BACKGROUND: Anticoagulation treatment after lower limb surgery is one of the key methods to avoid thrombosis, and low-molecular-weight heparin is the treatment that is most frequently used in clinical practice. But one uncommon side effect of low-molecular-weight heparin is heparin-induced thrombocytopenia (HIT), which can develop into thrombosis if not caught early or managed incorrectly. CASE SUMMARY: We present a case of a patient who underwent hip arthroplasty and experienced thrombocytopenia due to HIT on the 9(th) d following the application of low-molecular-weight heparin anticoagulation. We did not diagnose HIT in time and applied 1 unit of platelets to the patient, which led to thrombosis. Luckily, the patient recovered following effective and timely surgery and treatment with rivaroxaban. CONCLUSION: Patients using low-molecular-weight heparin after lower limb surgery need to have their platelet counts regularly checked. If HIT develops, platelet treatment should be given with caution. |
format | Online Article Text |
id | pubmed-10507566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-105075662023-09-20 Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report Lv, Fang-Fang Li, Mei-Ye Qu, Wei Jiang, Zhao-Shun World J Clin Cases Case Report BACKGROUND: Anticoagulation treatment after lower limb surgery is one of the key methods to avoid thrombosis, and low-molecular-weight heparin is the treatment that is most frequently used in clinical practice. But one uncommon side effect of low-molecular-weight heparin is heparin-induced thrombocytopenia (HIT), which can develop into thrombosis if not caught early or managed incorrectly. CASE SUMMARY: We present a case of a patient who underwent hip arthroplasty and experienced thrombocytopenia due to HIT on the 9(th) d following the application of low-molecular-weight heparin anticoagulation. We did not diagnose HIT in time and applied 1 unit of platelets to the patient, which led to thrombosis. Luckily, the patient recovered following effective and timely surgery and treatment with rivaroxaban. CONCLUSION: Patients using low-molecular-weight heparin after lower limb surgery need to have their platelet counts regularly checked. If HIT develops, platelet treatment should be given with caution. Baishideng Publishing Group Inc 2023-09-16 2023-09-16 /pmc/articles/PMC10507566/ /pubmed/37731576 http://dx.doi.org/10.12998/wjcc.v11.i26.6147 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Case Report Lv, Fang-Fang Li, Mei-Ye Qu, Wei Jiang, Zhao-Shun Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report |
title | Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report |
title_full | Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report |
title_fullStr | Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report |
title_full_unstemmed | Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report |
title_short | Rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: A case report |
title_sort | rivaroxaban for the treatment of heparin-induced thrombocytopenia with thrombosis in a patient undergoing artificial hip arthroplasty: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507566/ https://www.ncbi.nlm.nih.gov/pubmed/37731576 http://dx.doi.org/10.12998/wjcc.v11.i26.6147 |
work_keys_str_mv | AT lvfangfang rivaroxabanforthetreatmentofheparininducedthrombocytopeniawiththrombosisinapatientundergoingartificialhiparthroplastyacasereport AT limeiye rivaroxabanforthetreatmentofheparininducedthrombocytopeniawiththrombosisinapatientundergoingartificialhiparthroplastyacasereport AT quwei rivaroxabanforthetreatmentofheparininducedthrombocytopeniawiththrombosisinapatientundergoingartificialhiparthroplastyacasereport AT jiangzhaoshun rivaroxabanforthetreatmentofheparininducedthrombocytopeniawiththrombosisinapatientundergoingartificialhiparthroplastyacasereport |